Perigon Wealth Management’s Biogen BIIB Stock Holding History

Perigon Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$293K	Buy	1,600 +98	+7%	+$18.1K	0.01%	1029
2025 Q4	$264K	Buy	+1,502	New	+$245K	﹤0.01%	1072
2023 Q3	–	Sell	-787	Closed	-$224K	–	783
2023 Q2	$224K	Buy	+787	New	+$234K	0.01%	705
2021 Q1	–	Sell	-307	Closed	-$75K	–	546
2020 Q4	$75K	Buy	+307	New	+$79.2K	0.01%	618
2019 Q1	–	Sell	-770	Closed	-$259K	–	223
2018 Q4	$259K	Sell	770 -470	-38%	-$150K	0.07%	174
2018 Q3	$438K	Sell	1,240 -311	-20%	-$107K	0.11%	131
2018 Q2	$450K	Buy	1,551 +570	+58%	+$160K	0.14%	134
2018 Q1	$269K	Buy	981 +942	+2,415%	+$292K	0.1%	140
2017 Q4	$12K	Sell	39 -941	-96%	-$302K	﹤0.01%	471
2017 Q3	$307K	Buy	+980	New	+$290K	0.1%	152
2017 Q2	–	Sell	-34	Closed	-$9K	–	579
2017 Q1	$9K	Buy	34 +10	+42%	+$2.83K	﹤0.01%	531
2016 Q4	$7K	Buy	+24	New	+$7.11K	﹤0.01%	600

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Perigon Wealth Management's BIIB Position: Q1 2026 in Review

Perigon Wealth Management increased its Biogen (BIIB) stake by 6.5% in Q1 2026, buying an estimated $18.1K and bringing the position to 1,600 shares worth $293K. The position accounts for 0.01% of the portfolio, ranked #1029.

Perigon Wealth Management first reported a position in BIIB in Q4 2016 and has held it in 12 quarters since. The position peaked at $450K in Q2 2018. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

Perigon Wealth Management held 1,600 shares of Biogen worth $293K as of Q1 2026.
Perigon Wealth Management bought 98 Biogen shares in Q1 2026, an estimated $18.1K.
Biogen made up 0.01% of Perigon Wealth Management's portfolio in Q1 2026, its #1029 holding.
Perigon Wealth Management first reported a position in Biogen in Q4 2016 and has held it in 12 quarters since.
Perigon Wealth Management's Biogen position peaked at $450K in Q2 2018.
1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Perigon Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.